---
title: Cell and Gene Therapy Catapult vs Forge Biologics
slug_a: ct
slug_b: forgebiologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ct/forgebiologics
generated_by: BioBM Editorial AI
---

# Cell and Gene Therapy Catapult vs Forge Biologics

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Cell and Gene Therapy Catapult (ct) is listed for cdmo. UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle.

Services: 13. Modalities: 3. Indications: 4. Locations: 5. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (13).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Forge Biologics (forgebiologics) is listed for cdmo. Dedicated AAV gene therapy CDMO with a 200,000+ sq. ft. cGMP facility featuring 20 suites and bioreactors up to 5,000L, supporting 60+ clients across 35+ indications with high-yield manufacturing and seamless regulatory compliance.

Services: 12. Modalities: 2. Indications: 14. Locations: 4. Certifications: 5. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in indications (14).

Review summary: Review summary withheld until site-level review gate opens.